Learn more about our Health Equity work.
The op-ed unfairly and dangerously diminishes the value of cancer screening in reducing health disparities. As the writers acknowledge, numerous, complex factors contribute to poorer outcomes for Black patients than…
AdvaMed is engaged in efforts to ensure our industry is doing its part to mitigate the adverse impacts of health disparities among people and communities of color.
Two important developments just happened on the health equity and diversity front. One, the American Heart Association released a ground-breaking study finding women’s cardiovascular health is perhaps more poorly understood…
In the latest episode of Medtech POV, Nancy Brown, Chief Executive Officer of the American Heart Association, joins host Scott Whitaker to talk about her journey to leading one of…
Heart disease is the leading cause of death for both men and women in the United States, but historically—and even today—women are underrepresented in heart disease research, can be overlooked…
Artificial intelligence has been in the spotlight recently, but it is not a new concept to the Food and Drug Administration (FDA) or the medtech industry. AI advancements in the…
AdvaMed is dedicated to ensuring our industry focuses their efforts on treating and raising the awareness of women’s health conditions.
The final report of a three-part series investigates the prevalence of racial and ethnic disparities in the use of in the use of advanced interventions in the Medicare program.
The second of a three-phase research series examines the difference in access to certain advanced interventions, including a range of surgical, medical and technological interventions.
Racial and ethnic healthcare disparities in access to advanced interventions have persisted in the U.S. medical system. The first of a three-phase research series examines the difference in access to…